Maynard Um
-
-
-
-
-
-
-
Estrella Immunopharma reports positive phase 1 data for cancer therapy
-
-
-
-
-
-
-
Estrella Immunopharma (ESLA) Completes First Dose Cohort in STARLIGHT-1 Trial, Receives Approval to Initiate Higher Dose Cohort
-
-
471,230 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


